Prosight Management, LP Homology Medicines, Inc. Transaction History

Prosight Management, LP

  • $337 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$11.42 - $22.19 $1.75 Million - $3.4 Million
-153,303 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$14.74 - $22.28 $3.18 Million - $4.81 Million
-215,745 Reduced 58.46%
153,303 $2.78 Million
Q2 2019

Aug 14, 2019
BUY
$18.35 - $30.34 $6.77 Million - $11.2 Million
369,048 New
369,048 $7.22 Million

Others Institutions Holding FIXX

# of Institutions
3
Shares Held
66.2K
Call Options Held
0
Put Options Held
0
View Full List

About Homology Medicines, Inc.

FIXX Quotes by TradingView
  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track This Portfolio

Track Prosight Management, LP Portfolio

Follow Prosight Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Prosight Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email